Elmar Nimmesgern

Since March 2021 Policy Officer Health Research at the European Commission, Brussels. From December 2021 to November 2023 also interim Executive Director Global Health EDCTP3 Joint Undertaking, From September 2018 to March 2021 Secretariat Lead, Global AMR R&D Hub, Berlin. With the European Commission from 2000 to 2018, following different aspects of health research. Deputy Head of Unit from 2013 to 2018, initially in the Strategy Unit of the Health Directorate and from 2014 to 2018 in the Innovative and Personalised Medicine Unit. Previously 5 years at Vertex Pharmaceuticals in Cambridge/MA – USA, first research scientist biophysical chemistry, 1997 to 2000 project head preclinical programme IMPDH research (immunosuppressives). Biochemist by training; research on molecular chaperones at the University of Munich and at Memorial Sloan Kettering Cancer Center in New York.